News
The protein DNase1 is one of the oldest biological agents in history. It has been on the market since 1958 and is now used, ...
3d
News-Medical.Net on MSNYeast cells offer promising alternative for manufacturing DNase1The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, ...
3d
Interesting Engineering on MSNYeast cells brew human DNase1 for first time, paving way for cheaper treatmentScientists produce human DNase1 in yeast for the first time, opening doors to wider clinical use and easier manufacturing.
The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, among other things, to treat cystic fibrosis. However, it takes considerable ...
Neurodegenerative disorders have posed a major health challenge globally and the study explores the use of peptidomimetics as ...
The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in ...
The amount of cytoplasm in the neutrophil granulocytes in the blood smear had decreased significantly, and they contained no vacuoles and few granules. The structure (segmentation), size and colour ...
A single-cell analysis of nearly 18,000 white blood cells identifies a unique neutrophil subset characterized by type II ...
In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results